Nintedanib - CaLiGraph

Property	Value
rdf:type	owl:NamedIndividual Methyl ester Orphan drug Piperazine Tyrosine kinase inhibitor Drug granted breakthrough therapy designation
rdfs:label	Nintedanib
owl:sameAs	dbr:Nintedanib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Methyl_esters http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Piperazines http://en.wikipedia.org/wiki/List_of_drugs:_Im%E2%80%93In http://en.wikipedia.org/wiki/Boehringer_Ingelheim http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Tyrosine_kinase_inhibitors
skos:prefLabel	Nintedanib
skos:altLabel	intedanib nintedanib nintedanib (Ofev)
clgo:alternativeName	Vargatef, Ofev
clgo:bioavailability	4.7
clgo:casNumber	656247-17-5 656247-18-6
clgo:chEBI	85170 85164
clgo:chEMBL	3039504 502835
clgo:drugbank	DB09079 DBSALT001111
clgo:fdaUniiCode	42F62RTZ4G G6HRD2P839
clgo:kegg	D10396 D10481
clgo:medlinePlus	a615009
clgo:pubchem	9809715
is clgo:medication of	Idiopathic pulmonary fibrosis Pulmonary fibrosis

About: clgr:Nintedanib